Skip to content

Clinical effect of Qingre Jiedu Decoction on acute granulomatous mastitis

Clinical effect of Qingre Jiedu Decoction on acute granulomatous mastitis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100045855
Enrollment
Unknown
Registered
2021-04-25
Start date
2021-06-01
Completion date
Unknown
Last updated
2021-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

granulomatous mastitis

Interventions

Sponsors

Beijing Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Accord with the diagnostic criteria of granulomatous mastitis. 2. The diagnostic criteria of acute phase were met. 3. Women aged 18 to 60 years(including 18 and 60). 4. There was no TCM treatment in recent one month. 5. Informed consent, can cooperate with treatment, sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with breast cancer; 2. Allergic to known drugs in the prescription; 3. Patients with severe primary diseases such as cardio cerebrovascular, liver, kidney, hematopoietic system, or psychosis; 4. Pregnant and lactating women; 5. Participants in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Effective rate of breast redness and swelling area reduction;Effective rate of tumor area reduction;

Countries

China

Contacts

Public ContactZhang Dongxiao

Beijing Hospital of Traditional Chinese Medicine

morningdong@163.com+86 13811077684

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026